PhenylbutazonePhenylbutazone

4-Butyl-1,2-diphenyl-pyrazolidine-3,5-dione

Phenylbutazone (CAS 50-33-9) reference standard, produced and distributed by WITEGA Laboratorien Berlin-Adlershof GmbH, enables precise LC-MS/MS and GC-MS workflows from calibration to confirmatory analysis. This NSAID residue analysis standard supports traceable measurements in diverse matrices, and it integrates smoothly into routine quality control. As a result, laboratories can reach confident quantitative results with reduced rework.

This reference standard is designed for robust analytical quantification. Use it to prepare calibration curves, verify linearity, confirm identity, and assess method trueness. Moreover, Phenylbutazone aids in validating extraction efficiency and recovery. It fits well within multi-residue workflows and targeted methods alike, helping you demonstrate traceability, repeatability, and accuracy.

• Supports LC-MS/MS and GC-MS quantification with consistent response.
• Facilitates traceable calibration for reliable reporting.
• Strengthens method validation, including selectivity, LOD, and LOQ studies.
• Enables confirmatory analysis under regulatory requirements.

Typical use cases include regulated laboratories seeking defensible data, pharmaceutical research programs, residue control and surveillance, metabolism studies, and multi-residue method development. Additionally, the material helps standardize inter-laboratory comparisons and routine QA/QC checks. With Phenylbutazone as your reference standard, you can streamline verification steps and document strong performance characteristics.

Each lot is produced and distributed by WITEGA Laboratorien Berlin-Adlershof GmbH, ensuring dependable sourcing and expert technical support. Choose this reference standard to bolster traceability, enhance calibration robustness, and finalize confirmatory analysis with confidence.

You can download your Safety Data Sheet for NS064

For other languages please contact us: witega@witega.de